A Randomized Trial of Sibutramine in the Management of Obese Type 2 Diabetic Patients Treated With Metformin
Author(s) -
Steven McNulty,
Ehud Ur,
Gareth Williams
Publication year - 2003
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/diacare.26.1.125
Subject(s) - medicine , sibutramine , metformin , placebo , weight loss , glycemic , type 2 diabetes , blood pressure , diabetes mellitus , endocrinology , randomized controlled trial , obesity , alternative medicine , pathology
To evaluate the effects of sibutramine (15 and 20 mg/day) on weight, metabolic control, and blood pressure in metformin-treated obese subjects with type 2 diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom